anti-Hepatitis C Virus, gp70, E2 Specific antibody product blog
Tags: Antibody; Monoclonal Antibody; Hepatitis C Virus, gp70, E2 Specific; anti-Hepatitis C Virus, gp70, E2 Specific antibody;
The Hepatitis C Virus, gp70, E2 Specific n/a (Catalog #MBS601012) is an Antibody produced from Mouse and is intended for research purposes only. The product is available for immediate purchase. MyBioSource\'s Hepatitis C Virus, gp70, E2 Specific can be used in a range of immunoassay formats including, but not limited to, ELISA (EL/EIA), Western Blot (WB), Immunoprecipitation (IP), Immunohistochemistry (IHC), Immunocytochemistry (ICC).Suitable for use in ELISA, Western Blot, Immunoprecipitation, Immunohistochemistry and Immunocytochemistry.
Dilution: ELISA: 10-100ng/ml
Western Blot: 1-5ug/ml. Researchers should empirically determine the suitability of the Hepatitis C Virus, gp70, E2 Specific n/a for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Hepatitis C virus (HCV) is one of the leading causes of chronic liver diseases and B-lymphocyte proliferative disorders, including mixed cryoglobulinemia and B-cell lymphoma. It has been suggested that HCV infects human cells through the interaction of its envelope glycoprotein E2 with a tetraspanin molecule CD81, the putative viral receptor.
Immunogen: HCV E2 glycoprotein. In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing Hepatitis C Virus, gp70, E2 Specific are readily searchable from our website. Different antibodies against the same target such as Hepatitis C Virus, gp70, E2 Specific may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results.